• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

In vitro activity of sulbactam in combination with various beta-lactam antibiotics.

作者信息

Klastersky J, Van der Auwera P

机构信息

Laboratoire d'Investigation Clinique H.J. Tagnon, Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles, Belgium.

出版信息

Diagn Microbiol Infect Dis. 1989 Jul-Aug;12(4 Suppl):165S-169S. doi: 10.1016/0732-8893(89)90130-2.

DOI:10.1016/0732-8893(89)90130-2
PMID:2591176
Abstract

Forty-three strains (beta-lactamase positive and negative) from the species of Haemophilus influenzae, Neisseria gonorrhoeae, Staphylococcus aureus, Escherichia coli, Serratia marcescens, Enterobacter cloacae, Acinetobacter baumanii, and Pseudomonas aeruginosa were studied for synergy between sulbactam and several beta-lactam antibiotics. Using a checkerboard method, synergy was observed with 10 to 55% of the beta-lactamase negative strains. Synergy was more frequent with the strains producing beta-lactamase. Using the killing curve method, synergy was also observed between sulbactam and beta-lactam antibiotics against some beta-lactamase negative strains. In addition, the regrowth of a resistant subpopulation was prevented by sulbactam.

摘要

相似文献

1
In vitro activity of sulbactam in combination with various beta-lactam antibiotics.
Diagn Microbiol Infect Dis. 1989 Jul-Aug;12(4 Suppl):165S-169S. doi: 10.1016/0732-8893(89)90130-2.
2
In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.舒巴坦单独以及与氨苄西林、头孢噻肟、美洛西林和哌拉西林联合使用时，对临床上重要的革兰氏阳性和革兰氏阴性菌的体外活性。
Arzneimittelforschung. 1990 Oct;40(10):1145-55.
3
Beta-lactamase inhibitors from laboratory to clinic.从实验室到临床的β-内酰胺酶抑制剂
Clin Microbiol Rev. 1988 Jan;1(1):109-23. doi: 10.1128/CMR.1.1.109.
4
[Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2006].[2006年全国范围内含美罗培南的胃肠外抗生素对临床分离菌株活性的监测]
Jpn J Antibiot. 2007 Dec;60(6):344-77.
5
Combination beta-lactam and beta-lactamase-inhibitor products: antimicrobial activity and efficiency of enzyme inhibition.β-内酰胺类与β-内酰胺酶抑制剂联合制剂：抗菌活性及酶抑制效果
Am J Health Syst Pharm. 1995 Mar 15;52(6 Suppl 2):S15-22. doi: 10.1093/ajhp/52.6_Suppl_2.S15.
6
Sulbactam-containing beta-lactamase inhibitor combinations.含舒巴坦的β-内酰胺酶抑制剂复方制剂
Clin Microbiol Infect. 2008 Jan;14 Suppl 1:185-8. doi: 10.1111/j.1469-0691.2007.01847.x.
7
Amdinocillin: interaction with other beta-lactam antibiotics for gram-negative bacteria.氨曲南：与其他β-内酰胺类抗生素对革兰氏阴性菌的相互作用。
Chemotherapy. 1988;34(1):18-26. doi: 10.1159/000238542.
8
[Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. I. Effect of sulbactam against beta-lactams resistant strains and in vitro combined effect of sulbactam/cefoperazone with each of piperacillin, latamoxef, ceftazidime, fosfomycin and doxycycline].舒巴坦/头孢哌酮与其他抗生素对多重耐药菌株临床分离株的联合效应。I. 舒巴坦对β-内酰胺耐药菌株的作用以及舒巴坦/头孢哌酮与哌拉西林、拉氧头孢、头孢他啶、磷霉素和多西环素的体外联合效应
Jpn J Antibiot. 1990 Apr;43(4):636-58.
9
Studies on the synergism of sulbactam and beta-lactam antibiotics under in vitro conditions and in healthy volunteers after intravenous administration. Antibacterial activity in vitro, compatibility and pharmacokinetics of the drugs in combination.舒巴坦与β-内酰胺类抗生素在体外条件下及静脉给药后在健康志愿者体内的协同作用研究。联合用药的体外抗菌活性、相容性及药代动力学。
Arzneimittelforschung. 1989 Jan;39(1):94-100.
10
Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.β-内酰胺类与β-内酰胺酶抑制剂三种组合（哌拉西林/他唑巴坦、替卡西林/克拉维酸和氨苄西林/舒巴坦）体外活性的比较评价
Braz J Infect Dis. 2000 Feb;4(1):22-8.

引用本文的文献

1
Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates of Enterobacteriaceae.他唑巴坦、舒巴坦和克拉维酸增强氨苄西林对肠杆菌科临床分离株抗菌效力的相对疗效
Eur J Clin Microbiol Infect Dis. 1993 Mar;12(3):200-5. doi: 10.1007/BF01967112.
2
Comparison of fixed concentration and fixed ratio options for dilution susceptibility testing of gram-negative bacilli to ampicillin and ampicillin/sulbactam.革兰氏阴性杆菌对氨苄西林和氨苄西林/舒巴坦稀释药敏试验的固定浓度和固定比例选项比较。
Eur J Clin Microbiol Infect Dis. 1993 May;12(5):356-62. doi: 10.1007/BF01964434.
3
Therapy with cefoperazone plus sulbactam against disseminated infection due to cefoperazone-resistant Pseudomonas aeruginosa and Escherichia coli in granulocytopenic mice.
头孢哌酮联合舒巴坦治疗粒细胞缺乏小鼠由耐头孢哌酮铜绿假单胞菌和大肠杆菌引起的播散性感染。
Antimicrob Agents Chemother. 1993 Sep;37(9):1927-30. doi: 10.1128/AAC.37.9.1927.
4
Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid.单独使用哌拉西林以及与他唑巴坦联合使用的体外药效学研究，与替卡西林加克拉维酸的比较。
Antimicrob Agents Chemother. 1993 Sep;37(9):1860-8. doi: 10.1128/AAC.37.9.1860.
5
In-vitro susceptibility of cefoperazone-susceptible and -resistant gram-negative rods to cefoperazone plus sulbactam, other beta-lactams, aminoglycosides and quinolone.头孢哌酮敏感和耐药革兰氏阴性杆菌对头孢哌酮加舒巴坦、其他β-内酰胺类、氨基糖苷类和喹诺酮类的体外敏感性
Infection. 1991 Jan-Feb;19(1):49-53. doi: 10.1007/BF01643761.
6
Antimicrobial prophylaxis for major head and neck surgery in cancer patients: sulbactam-ampicillin versus clindamycin-amikacin.癌症患者头颈部大手术的抗菌预防：舒巴坦-氨苄西林与克林霉素-阿米卡星的比较
Antimicrob Agents Chemother. 1992 Sep;36(9):2014-9. doi: 10.1128/AAC.36.9.2014.
7
Comparison of fixed concentration and fixed ratio options for testing susceptibility of gram-negative bacilli to piperacillin and piperacillin/tazobactam.
Eur J Clin Microbiol Infect Dis. 1992 Aug;11(8):728-32. doi: 10.1007/BF01989979.